Implant Sciences Cp (IMSC) 0.9500 $IMSC
Implant Sciences To Announce Second Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Feb 13, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Tuesday, February 17, 2015 at 4:15 PM ET to discuss the financial results for the quarter ended December 31, 2014.
Implant Sciences Appoints Robert Liscouski as Executive Vice President
PR Newswire - Mon Feb 09, 6:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the appointment of Robert Liscouski into the newly created position of Executive Vice President. Mr. Liscouski will manage and drive the company's business strategy, business development and branding efforts. Mr. Liscouski will report to Dr. William McGann, Chief Executive Officer. Mr. Liscouski will continue to serve on the Company's Board of Directors.
Implant Sciences Board Announces Appointment of Dr. William McGann as CEO
PR Newswire - Tue Jan 20, 8:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that Chief Operating Officer William McGann has been named as the Company's Chief Executive Officer, effective immediately. Dr. McGann replaces Glenn D. Bolduc, who resigned his position on 16 January 2015 as Chief Executive Officer of the Company and his seat on the Company's Board of Directors.
Implant Sciences' Explosives and Drug Trace Detectors Approved for use in Russia
PR Newswire - Tue Jan 13, 6:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today its QS-B220 explosives and drugs trace detector has received regulatory approval in Russia for transportation. This approval covers various forms of transportation in Russia, including aviation, rail, and subways. In addition, both the QS-B220 and QS-H150 have also received the Customs Union Declaration of Conformity certification. These approvals allow Implant Sciences to sell the units to customers in Russia, Belarus, and Kazakhstan for the next five years, subject to U.S. export approval.
Implant Sciences' QS-B220 Receives Regulatory Approval for China Airports and Civil Aviation Industry
PR Newswire - Tue Dec 23, 9:48AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today its QS-B220 desktop explosives and drugs trace detector has received approval from the Civil Aviation Administration of China (CAAC).
IMSC SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Implant Sciences Corp.
PR Newswire - Tue Dec 09, 10:38AM CST
Levi & Korsinsky, LLP is investigating Implant Sciences Corp. (OTC: IMSC) in connection with possible claims of breaches of fiduciary duty.
Implant Sciences Receives Notification of Protest to Recent Award under Solicitation HTHS04-14-R-CT2050
PR Newswire - Wed Nov 26, 2:53PM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it has received notification that a bid protest has been filed with the Government Accountability Office (GAO) regarding the company's recent ETD award under Solicitation HTHS04-14-R-CT2050.
Implant Sciences' QS-B220 Named "Best Explosives Detection Solution" for the 2nd Consecutive Year
PR Newswire - Wed Nov 26, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today its QS-B220 desktop explosives and drugs trace detector has won the 2014 GSN Homeland Security Award for "Best Explosives Detection Solution". This marks the second year in a row that the QS-B220 has been given this award.
NATO Member Military Purchases 18 QS-H150 Explosives Trace Detectors from Implant Sciences
PR Newswire - Mon Nov 24, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the Company has won a competitive contract for 18 QS-H150s to be shipped to a county in the EMEA region (Europe, the Middle East and Africa). The country which made the purchase is a North Atlantic Treaty Alliance (NATO) member nation and will use Implant Sciences' handheld explosive trace detectors in military applications.
Implant Sciences to Conduct Press Conference & Demonstration of its QS-B220 Explosives Trace Detector on Monday, November 17 at 10:30am ET
PR Newswire - Fri Nov 14, 3:19PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will conduct a press conference on Monday, November 17, 2014 at 10:30 am ET at the Marriott Marquis Times Square, New York City. Implant Sciences will discuss significant recent Company events and will conduct live demonstrations of the QS-B220, which is the first non-radioactive explosives trace detector (ETD) to be approved for baggage and passenger screening by the TSA.
Implant Sciences Reports First Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Nov 14, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months ended September 30, 2014.
Implant Sciences Receives Order from TSA for 1,170 Explosive Trace Detectors
PR Newswire - Thu Nov 13, 11:11AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has placed an initial order for 1,170 QS-B220 Desktop Explosive Trace Detectors and ancillary supplies. The systems will be deployed at multiple airports across the country.
Implant Sciences To Announce First Quarter Fiscal 2015 Financial Results On November 14, 2014
PR Newswire - Wed Nov 12, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Friday, November 14, 2014 at 11:00 a.m. to discuss the financial results for the quarter ended September 30, 2014.
Implant Sciences signs TSA IDIQ Contract for up to $162 million dollars for explosive trace detection systems
PR Newswire - Tue Nov 11, 8:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has entered into an Indefinite Delivery / Indefinite Quantity (IDIQ) contract with the United States Transportation Security Administration (TSA) for its QS-B220 desktop explosives trace detectors, which recently received TSA qualification for airport checkpoint passenger and baggage screening. The IDIQ, a necessary prerequisite for competing for TSA's annual trace detection procurements, establishes contract terms under which the TSA could purchase up to $162 million of equipment and services.
Implant Sciences to Exhibit at Airport Council International's 2014 Airport Exchange in Paris on November 3 - 5, 2014
PR Newswire - Mon Nov 03, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will exhibit at booth C9 at Airport Council International's ACI Europe & ACI Asia-Pacific Airport Exchange 2014. ACI Airport Exchange is an important event in the air transport industry, with an expected attendance of more than 2,500 aviation business executives from Europe, Asia Pacific and around the world.
Implant Sciences to Sponsor Session on the Future of Aviation Security at AVSEC World 2014 Conference in Washington D.C.
PR Newswire - Mon Oct 27, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its participation in the 23rd Annual AVSEC World 2014 Conference on October 27 - 29, 2014 in Washington D.C. The Company will exhibit its QS-B220 explosives trace detector (ETD) at booth #17. The QS-B220 is the only ETD in the world that has been placed on the U.S. Transportation Security Administration's (TSA) Qualified Product List and passed the Common Evaluation Process (CEP) defined by the 44 member nation European Civil Aviation Conference (ECAC).
Implant Sciences Ships over $600,000 in Explosives Trace Detectors to Customers in Europe, the Middle East, and Africa
PR Newswire - Thu Oct 23, 11:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $600,000 in previously unannounced orders of QS-H150 and QS-B220s to multiple customers in Europe, the Middle East, and Africa. Customers for the handheld and desktop explosives trace detectors include airports, cargo companies, hotels, and petroleum industry facilities.
Implant Sciences Selected to Receive up to $2,000,000 from the Department of Homeland Security to Develop Next-Generation Explosives Trace Detection Systems
PR Newswire - Thu Oct 16, 11:12AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Department of Homeland Security has selected Implant Sciences' proposal to develop next generation explosives trace detection (ETD) screening systems for funding. The project, pending successful negotiations, is worth up to approximately $2 million to the Company.
Implant Sciences' QS-B220 Passes European Civil Aviation Conference Common Evaluation Process
PR Newswire - Mon Oct 06, 10:39AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 has successfully passed the European Civil Aviation Conference's (ECAC) Common Evaluation Process of Security Equipment (CEP) for airport checkpoint screening of passengers and baggage. The QS-B220 is the first Explosives Trace Detector (ETD) to pass ECAC's stringent laboratory testing protocol. The CEP was established to provide standards for security equipment performance across ECAC's 44 member nations. The QS-B220 was also recently added to the Transportation Security Administration's (TSA) Qualified Products List (QPL) in the U.S.
Implant Sciences Responds to Levi & Korsinsky, LLP Press Release/Solicitation
PR Newswire - Wed Oct 01, 7:00AM CDT
In response to a press release/general solicitation by the class action law firm, Levi & Korsinsky, LLP, Glenn D. Bolduc, CEO of Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, said today: "Levi & Korsinsky's press release/solicitation is identical to the press release it issued on August 8. The new release contains no new information and identifies no grounds whatsoever for an investigation of Implant Sciences or its board of directors. The firm has never contacted us directly, and we are not aware of any basis for an investigation. We do not believe this law firm's actions will benefit our shareholders, and we continue to encourage our shareholders and other interested parties to draw their own conclusions about the motivation behind this law firm's actions."
Implant Sciences To Announce Second Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Feb 13, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Tuesday, February 17, 2015 at 4:15 PM ET to discuss the financial results for the quarter ended December 31, 2014.
Implant Sciences Appoints Robert Liscouski as Executive Vice President
PR Newswire - Mon Feb 09, 6:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the appointment of Robert Liscouski into the newly created position of Executive Vice President. Mr. Liscouski will manage and drive the company's business strategy, business development and branding efforts. Mr. Liscouski will report to Dr. William McGann, Chief Executive Officer. Mr. Liscouski will continue to serve on the Company's Board of Directors.
Implant Sciences Board Announces Appointment of Dr. William McGann as CEO
PR Newswire - Tue Jan 20, 8:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that Chief Operating Officer William McGann has been named as the Company's Chief Executive Officer, effective immediately. Dr. McGann replaces Glenn D. Bolduc, who resigned his position on 16 January 2015 as Chief Executive Officer of the Company and his seat on the Company's Board of Directors.
Implant Sciences' Explosives and Drug Trace Detectors Approved for use in Russia
PR Newswire - Tue Jan 13, 6:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today its QS-B220 explosives and drugs trace detector has received regulatory approval in Russia for transportation. This approval covers various forms of transportation in Russia, including aviation, rail, and subways. In addition, both the QS-B220 and QS-H150 have also received the Customs Union Declaration of Conformity certification. These approvals allow Implant Sciences to sell the units to customers in Russia, Belarus, and Kazakhstan for the next five years, subject to U.S. export approval.
Implant Sciences' QS-B220 Receives Regulatory Approval for China Airports and Civil Aviation Industry
PR Newswire - Tue Dec 23, 9:48AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today its QS-B220 desktop explosives and drugs trace detector has received approval from the Civil Aviation Administration of China (CAAC).
IMSC SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Implant Sciences Corp.
PR Newswire - Tue Dec 09, 10:38AM CST
Levi & Korsinsky, LLP is investigating Implant Sciences Corp. (OTC: IMSC) in connection with possible claims of breaches of fiduciary duty.
Implant Sciences Receives Notification of Protest to Recent Award under Solicitation HTHS04-14-R-CT2050
PR Newswire - Wed Nov 26, 2:53PM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it has received notification that a bid protest has been filed with the Government Accountability Office (GAO) regarding the company's recent ETD award under Solicitation HTHS04-14-R-CT2050.
Implant Sciences' QS-B220 Named "Best Explosives Detection Solution" for the 2nd Consecutive Year
PR Newswire - Wed Nov 26, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today its QS-B220 desktop explosives and drugs trace detector has won the 2014 GSN Homeland Security Award for "Best Explosives Detection Solution". This marks the second year in a row that the QS-B220 has been given this award.
NATO Member Military Purchases 18 QS-H150 Explosives Trace Detectors from Implant Sciences
PR Newswire - Mon Nov 24, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the Company has won a competitive contract for 18 QS-H150s to be shipped to a county in the EMEA region (Europe, the Middle East and Africa). The country which made the purchase is a North Atlantic Treaty Alliance (NATO) member nation and will use Implant Sciences' handheld explosive trace detectors in military applications.
Implant Sciences to Conduct Press Conference & Demonstration of its QS-B220 Explosives Trace Detector on Monday, November 17 at 10:30am ET
PR Newswire - Fri Nov 14, 3:19PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will conduct a press conference on Monday, November 17, 2014 at 10:30 am ET at the Marriott Marquis Times Square, New York City. Implant Sciences will discuss significant recent Company events and will conduct live demonstrations of the QS-B220, which is the first non-radioactive explosives trace detector (ETD) to be approved for baggage and passenger screening by the TSA.
Implant Sciences Reports First Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Nov 14, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months ended September 30, 2014.
Implant Sciences Receives Order from TSA for 1,170 Explosive Trace Detectors
PR Newswire - Thu Nov 13, 11:11AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has placed an initial order for 1,170 QS-B220 Desktop Explosive Trace Detectors and ancillary supplies. The systems will be deployed at multiple airports across the country.
Implant Sciences To Announce First Quarter Fiscal 2015 Financial Results On November 14, 2014
PR Newswire - Wed Nov 12, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Friday, November 14, 2014 at 11:00 a.m. to discuss the financial results for the quarter ended September 30, 2014.
Implant Sciences signs TSA IDIQ Contract for up to $162 million dollars for explosive trace detection systems
PR Newswire - Tue Nov 11, 8:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has entered into an Indefinite Delivery / Indefinite Quantity (IDIQ) contract with the United States Transportation Security Administration (TSA) for its QS-B220 desktop explosives trace detectors, which recently received TSA qualification for airport checkpoint passenger and baggage screening. The IDIQ, a necessary prerequisite for competing for TSA's annual trace detection procurements, establishes contract terms under which the TSA could purchase up to $162 million of equipment and services.
Implant Sciences to Exhibit at Airport Council International's 2014 Airport Exchange in Paris on November 3 - 5, 2014
PR Newswire - Mon Nov 03, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will exhibit at booth C9 at Airport Council International's ACI Europe & ACI Asia-Pacific Airport Exchange 2014. ACI Airport Exchange is an important event in the air transport industry, with an expected attendance of more than 2,500 aviation business executives from Europe, Asia Pacific and around the world.
Implant Sciences to Sponsor Session on the Future of Aviation Security at AVSEC World 2014 Conference in Washington D.C.
PR Newswire - Mon Oct 27, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its participation in the 23rd Annual AVSEC World 2014 Conference on October 27 - 29, 2014 in Washington D.C. The Company will exhibit its QS-B220 explosives trace detector (ETD) at booth #17. The QS-B220 is the only ETD in the world that has been placed on the U.S. Transportation Security Administration's (TSA) Qualified Product List and passed the Common Evaluation Process (CEP) defined by the 44 member nation European Civil Aviation Conference (ECAC).
Implant Sciences Ships over $600,000 in Explosives Trace Detectors to Customers in Europe, the Middle East, and Africa
PR Newswire - Thu Oct 23, 11:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $600,000 in previously unannounced orders of QS-H150 and QS-B220s to multiple customers in Europe, the Middle East, and Africa. Customers for the handheld and desktop explosives trace detectors include airports, cargo companies, hotels, and petroleum industry facilities.
Implant Sciences Selected to Receive up to $2,000,000 from the Department of Homeland Security to Develop Next-Generation Explosives Trace Detection Systems
PR Newswire - Thu Oct 16, 11:12AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Department of Homeland Security has selected Implant Sciences' proposal to develop next generation explosives trace detection (ETD) screening systems for funding. The project, pending successful negotiations, is worth up to approximately $2 million to the Company.
Implant Sciences' QS-B220 Passes European Civil Aviation Conference Common Evaluation Process
PR Newswire - Mon Oct 06, 10:39AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 has successfully passed the European Civil Aviation Conference's (ECAC) Common Evaluation Process of Security Equipment (CEP) for airport checkpoint screening of passengers and baggage. The QS-B220 is the first Explosives Trace Detector (ETD) to pass ECAC's stringent laboratory testing protocol. The CEP was established to provide standards for security equipment performance across ECAC's 44 member nations. The QS-B220 was also recently added to the Transportation Security Administration's (TSA) Qualified Products List (QPL) in the U.S.
Implant Sciences Responds to Levi & Korsinsky, LLP Press Release/Solicitation
PR Newswire - Wed Oct 01, 7:00AM CDT
In response to a press release/general solicitation by the class action law firm, Levi & Korsinsky, LLP, Glenn D. Bolduc, CEO of Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, said today: "Levi & Korsinsky's press release/solicitation is identical to the press release it issued on August 8. The new release contains no new information and identifies no grounds whatsoever for an investigation of Implant Sciences or its board of directors. The firm has never contacted us directly, and we are not aware of any basis for an investigation. We do not believe this law firm's actions will benefit our shareholders, and we continue to encourage our shareholders and other interested parties to draw their own conclusions about the motivation behind this law firm's actions."
